Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

Hypertension
G GrassiG Mancia

Abstract

Studies performed in experimental animals and in humans have documented that high blood pressure markedly impairs baroreceptor control of heart rate. Whether a similar impairment also characterizes baroreceptor control of sympathetic activity modulating peripheral vasomotor tone is still unknown. In 28 untreated essential hypertensive subjects [14 of moderate and 14 of more severe degree, age 51.6+/-2.4 and 52.6+/-2.1 years (mean+/-SEM)] and in 13 untreated secondary hypertensives (renovascular or pheochromocytoma, age 50.1+/-4.6 years), we measured beat-to-beat arterial blood pressure (finger photoplethysmographic device), heart rate (electrocardiogram), and efferent postganglionic muscle sympathetic nerve activity (microneurography) at rest and during baroreceptor stimulation and deactivation induced by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Data were compared with those obtained in 15 age-matched normotensive control subjects. Muscle sympathetic nerve activity (bursts per 100 heart beats) showed a progressive and significant (P<.01) increase from normotension (40.3+/-3.3) to moderate (55.6+/-4.1) and more severe essential hypertension (68.2+/-4.1), paralleling the progressive increas...Continue Reading

References

Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·F ManteroM Boscaro
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·G ManciaA Zanchetti
Apr 1, 1982·Physiological Reviews·B Folkow
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·G SimonD K Snyder

❮ Previous
Next ❯

Citations

Apr 25, 2012·Applied Microbiology and Biotechnology·Bao-Hong Lee, Tzu-Ming Pan
Jul 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Guido GrassiGiuseppe Mancia
Jan 25, 2005·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Jens Jordan
Mar 31, 2011·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Jens TankJens Jordan
Jan 15, 2013·Journal of Clinical Monitoring and Computing·Guadalupe Dorantes MendezManuela Ferrario
Sep 12, 2000·Current Hypertension Reports·M Johansson, P Friberg
May 7, 2004·Current Hypertension Reports·Guido Grassi
May 24, 2007·Current Hypertension Reports·Guido Grassi, Fosca Quarti Trevano
Feb 5, 2011·Current Hypertension Reports·Emma C Hart, Nisha Charkoudian
Nov 10, 2011·Current Hypertension Reports·Gemma CurrieAnna F Dominiczak
Mar 30, 2012·Current Hypertension Reports·Michael DoumasVasilios Papademetriou
May 30, 2013·Current Hypertension Reports·Monica M SantistebanMohan K Raizada
Jul 18, 2000·Journal of the American College of Cardiology·L E SpiekerG Noll
Nov 13, 2001·Journal of the American College of Cardiology·J P GreenwoodD A Mary
Jul 10, 2002·Journal of the American College of Cardiology·Paul A SmithDavid A S G Mary
Oct 19, 2011·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Christopher P FagundesJanice K Kiecolt-Glaser
Jul 30, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jacek LewandowskiZbigniew Gaciong
Apr 5, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Xingjiang XiongJie Wang
May 1, 2009·Journal of Human Hypertension·Y Al-SolaimanB M Egan
Jun 12, 2009·Journal of Human Hypertension·B Franjic, T H Marwick
Apr 8, 2011·Journal of Human Hypertension·S GoulopoulouJ A Kanaley
Jul 8, 2011·Journal of Human Hypertension·J P Fisher, J F R Paton
Oct 4, 2013·Journal of Human Hypertension·A J A McLellanM P Schlaich
Dec 15, 2006·Journal of Human Hypertension·A J HogarthD A S G Mary
Mar 9, 2007·Journal of Human Hypertension·C C CallegaroJ P Ribeiro
Jul 28, 2001·European Journal of Clinical Investigation·J E DonckierJ L Balligand
May 26, 2009·European Heart Journal·Andrew J HogarthJohn P Greenwood
Dec 12, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jan MenneHermann Haller
May 11, 2001·Journal of Cardiovascular Pharmacology·G Mancia, G Grassi
Dec 23, 2004·Journal of Cardiovascular Pharmacology·Markus BéchirGeorg Noll
Aug 10, 2004·Current Opinion in Nephrology and Hypertension·Guido Grassi
Jan 12, 2001·Blood Pressure Monitoring·C L ForjazC E Negrão
Nov 22, 2007·Journal of Cardiovascular Pharmacology·Sara Del ColleFranco Veglio
May 10, 2012·Journal of Cardiovascular Pharmacology·Amy C ArnoldDebra I Diz
May 12, 2010·Shock·C Geraldine McMahonEmrys Kirkman
Apr 28, 2005·Clinical and Experimental Pharmacology & Physiology·R A L DampneyL M McDowall
Apr 28, 2005·Clinical and Experimental Pharmacology & Physiology·E Sankaranarayanan PrakashSunil K Narayan
Jan 31, 2012·Clinical and Experimental Pharmacology & Physiology·D D GuimarãesV A Braga
Dec 5, 2008·International Journal of Clinical Practice·H E Bays, D J Rader
Aug 31, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Erin P DelaneyWilliam B Farquhar
Apr 13, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Hema RainaW Gil Wier
Apr 5, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Amy C ArnoldDebra I Diz
Sep 9, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Maria Maliszewska-ScisloNoreen F Rossi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.